Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative takeover targets, and a third is a possible target as well.
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what…
August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector while consumer discretionary stocks weighed most heavily. WTI crude oil for September…
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
In the latest Merrill Lynch RIC Report, which is effectively a culmination of the firm's top research ideas, views and advice for clients, the one common theme throughout was where to find…
The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that the rising tide did not actually lift all ships. There were over…
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
The short interest data for the July 29 settlement date are out and it almost feels like short sellers are getting a bit panicked about the market rally.
August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength this afternoon…
Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.
August 2, 2016: Markets opened nearly flat again Tuesday on stronger oil prices early in the day before reality set in. As it is, energy is the sole sector that trades higher…
